# Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60

> **NCT00121589** · PHASE1 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 40 (—)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Lutein

## Key facts

- **NCT ID:** NCT00121589
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07-14
- **Primary completion:** —
- **Final completion:** 2007-08-15
- **Target enrollment:** 40 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121589, "Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00121589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*